GPRC5D CAR T cells (OriCAR-017) in patients with relapsed or refractory multiple myeloma (POLARIS): a first-in-human, single-centre, single-arm, phase 1 trial
Pharmacology, Toxicology and Pharmaceutical Science
4
6%
Immunology and Microbiology
4
6%
Agricultural and Biological Sciences
3
5%
Other
6
9%
Unknown
31
47%
Attention Score in Context
Attention Score in Context
This research output has an Altmetric Attention Score of 366. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 April 2023.
All research outputs
#93,728
of 26,779,733 outputs
Outputs from The Lancet Haematology
#16
of 1,379 outputs
Outputs of similar age
#2,447
of 494,188 outputs
Outputs of similar age from The Lancet Haematology
#1
of 37 outputs
Altmetric has tracked 26,779,733 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,379 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 29.7. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 494,188 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 37 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.
